Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center >> Industry news

Discharge Opioid Rx for Heart Dz Patients May Impact Follow-Up

Discharge Opioid Rx for Heart Dz Patients May Impact Follow-Up FRIDAY, Feb. 15, 2019 -- For patients with an admitting diagnosis of acute coronary syndrome and/or acute decompensated heart failure, opioid prescription at discharge is not significantly as

FDA Approves Darzalex (daratumumab) Split-Dosing Regimen

FDA Approves Darzalex (daratumumab) Split-Dosing Regimen Horsham, PA, February 12, 2019 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved a split-dosing regimen for D